-
Glaukos Shares Soar After Competing Stent Removed From Market
Wednesday, August 29, 2018 - 11:01am | 392Glaukos Corp (NYSE: GKOS) stock skyrocketed Wednesday after one of the company’s major competitors removed its product from the market. What Happened Alcon announced that it's voluntarily withdrawing its CyPass Micro-Stent from the market following new data from a five-year,...
-
William Blair & Company Maintains Meridian Bioscience (VIVO) Market Perform Rating
Thursday, March 18, 2010 - 11:43am | 218William Blair & Company analyst Brian Weinstein maintained his Market Perform rating for shares of Meridian Bioscience Inc. (Nasdaq: VIVO). Although Meridian Bioscience Inc. lowered its sales and earnings guidance significantly, the main reason behind the move was an industry wide issue. The...